Athenex Announces Details of Investor Event and Webcast at SABCS on December 13, 2019

NEXT STORY
APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen
PREV STORY
Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Provides Research and Development Update

author_avatar
NASDAQ Market News

VBI Vaccines Announces Positive Top-Line Results from PROTECT, a Pivotal Phase 3 Study of Sci-B-Vac®

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

author_avatar
NASDAQ Market News